The August/September 2024 issue of AAOS Now includes the first of of a two-part series…
Countdown the Top 5 of 2023 with CurveBeam AI
As we approach the end of this remarkable year, we want to take a moment to reflect on the incredible journey we’ve in 2023. Here are the top 5 achievements that have defined our year from getting listed on the ASX to announcing research & development has commenced for the SkyRise. Each of these milestones has been a stepping stone toward our collective vision, and we can’t wait to celebrate them with you.
In August, 2023, CurveBeam AI was listed on the Australian Securities Exchange (ASX) under ticker symbol CVB.
Pictured right: CurveBeam AI COO, CTO (CT), & President (Americas & Europe) Arun Singh (left) and CurveBeam AI CEO Greg Brown (right) ring the bell at the ASX Exchange Centre on opening day.
An AI-powered measurement and analysis platform, CubeVue Autometrics will provides instant 2D and 3D measurements to aid in clinical evaluation and surgical decision making. CurveBeam AI worked with clinical and research partners around the globe to advance the platform.
Investigational only; not available for sale in the United States.
CurveBeam AI announced develpment of Axiometrics (patent pending), a software tool that enables semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle.
Click on the image to the left to learn how and why Dr. Andy Goldberg was inspired to work with CurveBeam AI to create Axiometrics.
CurveBeam AI installed HiRise weight bearing CT imaging systems in the United States, Europe and Australia. CurveBeam AI worked closely with customers to increase patient access to low dose standing imaging.
CurveBeam AI announced research and development has commenced on the SkyRise, a weight bearing CT imaging system for the body, including shoulder and spine.
We look forward to expanding our network further as we add these new capabilities to our product portfolio.
Investigational only; not available in the United States.
Related Posts
